Neuren Pharmaceuticals Ltd (STU:NK9)
€ 7.5 -0.05 (-0.66%) Market Cap: 994.12 Mil Enterprise Value: 797.16 Mil PE Ratio: 13.25 PB Ratio: 4.91 GF Score: 28/100

Neuren Pharmaceuticals Ltd Annual Shareholders Meeting Transcript

May 28, 2024 / 04:30AM GMT
Patrick Davies
Neuren Pharmaceuticals Ltd - Non-Executive Lead Independent Director

Good afternoon, everybody. My name is Patrick Davies. I'm the Non-Executive Chair of Neuren Pharmaceuticals. It's my pleasure to welcome you to Neuren's Annual Shareholder Meeting.

It's pretty clear in the room, we have a quorum present. And I therefore declare the meeting open. Before we proceed with the meeting, I have a couple of quick housekeeping points. (Event Instructions)

We are pleased to facilitate a hybrid meeting through the Link Market Services online platform, enabling shareholders to participate in the meeting irrespective of where they are in the world. I'll welcome those of you participating online.

The agenda for the meeting will be as follows. Firstly, I'll present my address. Following that, Jon Pilcher, our CEO and Managing Director will present his review of Neuren's activities. We will then proceed with the formal business of the meeting, which includes the resolutions. Following the conclusion of the meeting, I invite those shareholders here in person to join me, my

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot